Evidence map›Paper›PMID 11046157›Full record

ArticleMolecular and cellular biology2000

Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases.

M Saleh, I Rambaldi, X J Yang, M S Featherstone

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 195 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. eLife · 2020
    Article
  7. Article
  8. Article
  9. Article
  10. Functional testing of a humanDisease models & mechanisms · 2018
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Contrasting roles for MyoD in organizing myogenic promoter structures during embryonic skeletal muscle development.Developmental dynamics : an official publication of the American Association of Anatomists · 2015
    Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

M SalehMcGill Cancer Centre, McGill University, Montréal, Québec, Canada H3G 1Y6.
I Rambaldi
X J Yang
M S Featherstone
McGill University Health Centre · CAMolecular Oncology (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Hoxb1 autoregulatory element comprises three HOX-PBX binding sites. Despite the presence of HOXB1 and PBX1, this enhancer fails to activate reporter gene expression in retinoic acid-treated P19 cell monolayers. Activation requires cell aggregation in addition to RA. This suggests that HOX-PBX complexes may repress transcription under some conditions. Consistent with this, multimerized HOX-PBX binding sites repress reporter gene expression in HEK293 cells. We provide a mechanistic basis for repressor function by demonstrating that a corepressor complex, including histone deacetylases (HDACs) 1 and 3, mSIN3B, and N-CoR/SMRT, interacts with PBX1A. We map a site of interaction with HDAC1 to the PBX1 N terminus and show that the PBX partner is required for repression by the HOX-PBX complex. Treatment with the deacetylase inhibitor trichostatin A not only relieves repression but also converts the HOX-PBX complex to a net activator of transcription. We show that this activation function is mediated by the recruitment of the coactivator CREB-binding protein by the HOX partner. Interestingly, HOX-PBX complexes are switched from transcriptional repressors to activators in response to protein kinase A signaling or cell aggregation. Together, our results suggest a model whereby the HOX-PBX complex can act as a repressor or activator of transcription via association with corepressors and coactivators. The model implies that cell signaling is a direct determinant of HOX-PBX function in the patterning of the animal embryo.

Indexed as

Saccharomyces cerevisiae ProteinsAcetyltransferasesAnimalsBinding SitesCell LineCREB-Binding ProteinCyclic AMP-Dependent Protein KinasesDNA-Binding ProteinsEnhancer Elements, GeneticEnzyme InhibitorsHistone AcetyltransferasesHistone Deacetylase InhibitorsHistone DeacetylasesHomeodomain ProteinsHumansHydroxamic AcidsAcetyltransferasesCREB-Binding ProteinCREBBP protein, humanCrebbp protein, mouseCyclic AMP-Dependent Protein KinasesDNA-Binding ProteinsEnzyme InhibitorsHistone AcetyltransferasesHistone Deacetylase InhibitorsHistone DeacetylasesHomeodomain ProteinsHOXB1 homeodomain proteinHOXD10 protein, humanHoxd4 protein, mouseHydroxamic AcidsNuclear ProteinsPBX1 protein, humanPre-B-Cell Leukemia Transcription Factor 1Proto-Oncogene ProteinsRepressor ProteinsSaccharomyces cerevisiae ProteinsTrans-ActivatorsTranscription Factorstrichostatin A

Identifiers

PMID11046157
PMCPMC102167
OpenAlexW2105635571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.